Track and trace regulations can deliver many benefits: Reduction of tax evasion, prevention of counterfeit goods entering a market, enhancing patient safety, brand protection, better control over supply chains. Consequently, track and trace regulations are now commonplace in the pharmaceutical industry and are being considered for or are already introduced into other industries, for example, tobacco, explosives and luxury goods. Other organizations and public bodies are evaluating how to apply the use of track and trace models to ensure the integrity of their supply chains. Regulated markets frequently require products to be aggregated and the aggregation hierarchy information to be reported as well as the product disposition data.
Any government or public sector regulatory body wishing to introduce a centralized regulatory regime or model will need to establish a regulatory platform to receive reports and data from the regulated supply chain participants.
In this Rethink:TMRW Summit presentation from 2022, Uwe Rauschenberg and Mark Genn are introducing the Engineering Industries eXcellence, formerly Movilitas project for the UAE to develop a national system for pharma traceability.
